t(11;14) Negative
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Ixazomib and Dexamethasone With or Without Venetoclax in Treating Patients With Non-t(11;14) Relapsed or Refractory Multiple Myeloma (NCT03856112) | National Cancer Institute (NCI) | 2019-06-21 |
Track t(11;14) Negative automatically
Every clearance here is in the API, with alerts when new ones post.